In plain words
as of 20 Nov 2026Over 5 years it returned 15.6% a year, above the middle Equity ETFs fund (9.0%) by 6.6 points.
Trailed its benchmark by 0.2 points a year over 5 years (15.6% vs 15.8%).
Its ups and downs have been smaller than most funds in its category. Volatility 15.6% vs a category middle of 17.6%.
The deepest fall was −20.6% (Sep 2021 to Jun 2022); it recovered in 398 days.
Of every 1-year period since launch, 23% ended below where they started. The middle 1-year result was 12.7%.
This is a Regular plan: it pays a distributor commission inside its fee. The Direct plan holds the same portfolio at a lower cost.
Key facts
- Fund house
- ICICI Prudential Mutual Fund
- Category
- Equity ETFs (SEBI)
- Plan & option
- Regular · Growth
- Benchmark i
- NIFTY Healthcare TRI (tracked via ICICI Prudential Nifty Healthcare ETF)
- First NAV
- 21 May 2021 · 5.5 years of history · 1,360 NAVs
- AMFI code
- 148957
- ISIN
- INF109KC1Q72
- Expense ratio i
- 0.18%
- Fund size
- ₹240 Cr
How ₹100 grew
Returns
Up to 1 year: total change. Longer: yearly (CAGR) i| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch | |
|---|---|---|---|---|---|---|---|---|---|---|
| This fund | +12.33% | +6.11% | +10.49% | +19.80% | +17.86% | +20.75% | +15.62% | — | — | +14.84% |
| NIFTY Healthcare TRI* | +12.35% | +6.16% | +10.59% | +20.00% | +18.07% | +20.97% | +15.83% | — | — | — |
| Equity ETFs middle fund i | +9.44% | +2.23% | +7.03% | +1.53% | +0.66% | +11.16% | +8.98% | +12.69% | +13.37% | — |
Category middle = median Regular Growth fund in Equity ETFs (101 funds with 3 years). * Benchmark approximated by ICICI Prudential Nifty Healthcare ETF with its expense ratio added back. Blank means not enough history, never zero.
Risk and risk-adjusted return
Last 36 months · risk-free rate 6.5%Against its benchmark
NIFTY Healthcare TRI · 36 monthly returnsThe worst it has been
Every 1-year period i
One 5-year number depends on its start date. These show what happened across every start date in the fund's life.
What it holds
filed for 31 Oct 2026Asset mix
Company size
How concentrated
Largest sector: Pharmaceuticals & Biotechnology at 81.8%.
Largest holdings
| Holding | Sector | Weight |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 16.33% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 10.78% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | 8.12% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | 7.54% |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 7.15% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | 6.73% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 5.89% |
| MAX Healthcare Institute Ltd | Healthcare Services | 5.55% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | 4.24% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | 4.03% |
| Fortis Healthcare Ltd. | Healthcare Services | 3.47% |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 3.00% |
| Zydus Lifesciences Ltd. | Pharmaceuticals & Biotechnology | 2.68% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | 2.67% |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | 2.45% |
| IPCA Laboratories Ltd. | Pharmaceuticals & Biotechnology | 2.33% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | 2.14% |
| Biocon Ltd. | Pharmaceuticals & Biotechnology | 2.13% |
| Krishna Institute of Medical Sciences | Healthcare Services | 1.62% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | 1.15% |
Sectors
What the manager did last month
30 Sep 2026 → 31 Oct 2026A holding's value moves with its price; only a change in the number of shares is a decision. These lists use share counts. A split or bonus also changes share counts, so check sudden round multiples.
Added to 20
Against similar funds
Top Equity ETFs Regular Growth funds by return. A sort by one past number, not a recommendation.
| Fund | Return | Volatility | Sharpe | Alpha | Beta | Deepest fall | Stars |
|---|---|---|---|---|---|---|---|
| DSP Nifty PSU Bank ETF DSP | +25.45% | 26.0% | 0.73 | +0.29% | 1.00 | −29.70% | Not rated |
| ICICI Prudential Nifty PSU Bank ETF ICICI Pru | +25.31% | 26.0% | 0.72 | +0.16% | 1.00 | −29.70% | Not rated |
| Kotak Nifty PSU Bank ETF Kotak | +25.09% | 26.0% | 0.71 | −0.00% | 1.00 | −80.72% | Not rated |
| Motilal Oswal BSE Healthcare ETF Motilal Oswal | +21.96% | 15.4% | 1.01 | — | — | −16.15% | Not rated |
| Aditya Birla Sun Life Nifty Healthcare ETF ABSL | +20.88% | 15.7% | 0.92 | +0.06% | 1.00 | −18.27% | Not rated |
| ICICI Prudential Nifty Healthcare ETF ICICI Pru | +20.75% | 15.6% | 0.91 | +0.00% | 1.00 | −20.63% | Not rated |
| ICICI Prudential Nifty Auto ETF ICICI Pru | +20.54% | 21.4% | 0.66 | +0.00% | 1.00 | −28.25% | Not rated |
| Axis NIFTY Healthcare ETF Axis | +20.48% | 15.6% | 0.89 | −0.22% | 1.00 | −20.70% | Not rated |
| Motilal Oswal BSE Enhanced Value ETF Motilal Oswal | +19.63% | 21.6% | 0.61 | — | — | −21.81% | Not rated |
| Mirae Asset Nifty India Manufacturing ETF Mirae Asset | +17.55% | 17.3% | 0.64 | — | — | −23.17% | Not rated |
Compare side by side with another Equity ETFs fund
If you had run a SIP i
₹10,000 on the first NAV of every month for 5 years: ₹6,00,000 invested would be worth ₹9,80,628 on 20 Nov 2026.
XIRR counts each instalment for the time it was invested, so it is the return a SIP investor actually got.
Try your own amount and datesAll plans and options
| Scheme | NAV | AMFI code |
|---|---|---|
| Regular · Growth | ₹179.3784 | 148957 |
About Equity ETFs funds
- The rule
- Exchange-traded fund that tracks an equity index; bought on the stock exchange.
- Who it can suit
- Investors with a demat account who want low-cost index exposure.
- Typical holding period
- 5 years or more
Questions people ask
What is the NAV of ICICI Prudential Nifty Healthcare ETF?
₹179.3784 as of 20 Nov 2026, from AMFI's daily NAV file. NAVs are published once every business day after markets close.
Direct or Regular: what is the difference?
Same portfolio. Regular pays a distributor commission inside its fee, so it returns a little less every year.
Growth or IDCW?
Growth reinvests everything. IDCW pays some out, so its NAV drops after each payout and its NAV-based return understates what investors received.
How are these numbers calculated?
Every figure is computed by Growth from the fund's published NAV history. See How we calculate.